Boyko B.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- A 52-week, randomised, double blind, multicentre, 2-arm parallel group trial assessing the efficacy and safety of CHF6001 (total daily dose 3200 μg) Dry Powder Inhaler (DPI) add-on to maintenance medium or high dose inhaled corticosteroid in combination with long-acting ß2-agonists in subjects with uncontrolled asthma
- Efficacy and Safety Evaluation of Verekitug (UPB-101) in Adults with Severe Asthma: A Phase 2 Randomized, Double-blind, Placebo-controlled Study
- Efficacy and Safety of BI 1291583 in Patients with Bronchiectasis: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 49 of 280 partner sites.
Specializations
Respiratory Medicine
Clinical research activity includes asthma, severe asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis, with attention to symptom control, exacerbation reduction, and lung function.
- Asthma exacerbations
- COPD and cardiopulmonary outcomes
- Bronchiectasis pulmonary exacerbations
Work in this area is linked to pulmonary care at Diagnostic And Consulting Center 1 Pernik EOOD and Rahila Angelova Mbal AD.
Allergic and Inflammatory Skin Disease
Therapeutic interest extends to chronic spontaneous urticaria, chronic urticaria, and nonsegmental vitiligo, reflecting involvement in immune-mediated disorders with dermatologic and symptomatic burden.
- Chronic spontaneous urticaria (CSU)
- Chronic urticaria
- Nonsegmental vitiligo
This research area includes evaluation of treatments aimed at itch, hives, and skin repigmentation-related disease management.
Neuropsychiatric Disorders in Dementia
Clinical trial involvement includes agitation in Alzheimer’s disease dementia and hallucinations and delusions associated with Alzheimer’s disease psychosis, focusing on behavioral and psychotic symptoms in neurodegenerative illness.
- Agitation in dementia of the Alzheimer’s type
- Alzheimer’s disease psychosis
- Hallucinations and delusions
The therapeutic scope reflects interest in neuropsychiatric symptom control within memory-disorder care.
Cardiorenal and Vascular Medicine
Research activity also covers chronic kidney disease (CKD) with hypertension, atherosclerotic cardiovascular disease, and broader cardiovascular risk, including outcomes related to major adverse events and renal decline.
- CKD and hypertension
- Atherosclerotic cardiovascular disease
- MACE-PLUS risk reduction
This domain also includes interest in albuminuria and renal-cardiovascular protection.
Infectious Disease and COVID-19
Clinical trial participation includes COVID-19 in nonhospitalized patients at high risk of progression to severe illness, adding an infectious-disease dimension to the investigator’s portfolio.
- COVID-19 with risk of severe progression
- Outpatient antiviral treatment
This area complements the investigator’s work in internal medicine and acute-risk patient management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.